Tumor necrosis factor gene polymorphisms in ankylosing spondylitis

Tissue Antigens

Volumn 51, Issue 4 I, 1998, Pages 386-390

  Fraile, A ^a   Nieto, A ^a   Beraun Y ^a   Vinasco, J ^a   Mataran L ^b   Martin J ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

Ankylosing spondylitis; HLA B*27; TNF

Indexed keywords

HLA B ANTIGEN; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ANKYLOSING SPONDYLITIS; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENOTYPE; HISTOCOMPATIBILITY GENE; HUMAN; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ALLELES; HLA-B27 ANTIGEN; HUMANS; LINKAGE DISEQUILIBRIUM; LYMPHOTOXIN-ALPHA; POLYMORPHISM, GENETIC; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031958392     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1998.tb02978.x     Document Type: Article

References (18)

1. Ruddle NH. Tumor necrosis factor (TNF-α) and lymphotoxin (TNF-β). Curr Opin Immunol 1992: 4: 327-332.
2. Gratacos J, Collado A, Filella X et al. Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. Br J Rheumatol 1994: 33: 927-931.
3. Braun J, Bollow M, Neure L et al. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 1995: 38: 499-505.
4. Repo H, Jäättelä M, Leirasalo-Repo M, Hurme M. Production of tumor necrosis factor and interleukin 1 by monocytes of patients with previous Yersinia arthritis. Clin Exp Immunol 1988: 72: 410-414.
5. Wilson AG, Gordon C, di Giovine FS et al. A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. Eur J Immunol 1994: 24: 191-195.
6. Galbraith GMP, Pandey JP. Tumor necrosis factor alpha (TNFα) gene polymorphism in alopecia areata. Hum Genet 1995: 96: 433-436.
7. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 1997: 94: 3195-3199.
8. Pociot F, d'Alfonso S, Compasso S, Scorza R, Richiardi PM. Functional analysis of a new polymorphism in the human TNF alpha gene promoter. Scand J Immunol 1995: 42: 501-504.
9. Pociot F, Briant L, Jongeneel CV et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993: 23: 224.
10. Abraham LJ, French MA, Dawkins RL. Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor-alpha. Clin Exp Immunol 1993: 92: 14-8.
11. Messer G, Spengler U, Jung MC et al. Allelic variation in the TNF-β does not explain the low TNF-β response in patients with primary biliary cirrhosis. Scand J Immunol 1991: 34: 735-740.
12. van der Linden S, Valkenburgh HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984: 27: 361-368.
13. Nieto A, Fraile A, Vinasco J, Martín J. HLA-B*27 typing by PCR-restriction fragment length polymorphism. Tissue Antigens 1997: 49: 283-286.
14. Vinasco J, Beraun Y, Nieto A et al. Polymorphism at the TNF loci in rheumatoid arthritis. Tissue Antigens 1997: 49: 74-78.
15. Zimmerman PA, Guderain RH, Nutman TB. A new TNFA promoter allele identified in South American Blacks. Immunogenetics 1996: 44: 485-486.
16. Dyer P, Warrens A. Design and interpretation of studies of the major histocompatibility complex in disease. In: R. Lechler, ed. HLA & disease. London: Academic Press Limited, 1994: 93-122.
17. Verjans GM, Brinkman BMN, Van Doornik CEM, Kijlstra A, Verweij CL. Polymorphism of the tumor necrosis factor-alpha (TNFα) at position -308 in relation to ankylosing spondylitis. Clin Exp Immunol 1994: 97: 45-47.
18. Verjans GM, van der Linden SM, van Eys GJ, de Waal LP, Kijlstra A. Restriction fragment length polymorphism of the tumor necrosis factor region in patients with ankylosing spondylitis. Arthritis Rheum 1991: 34: 486-489.